B. Aubry-Rozier

Discipline

Psychologie (3) Linguistique (1) Education (1)

Type de document

Articles (17) Recensions (4) Colloques et conférences (2) Autres (1)

Co-auteur

Date

Source

Mot-clé

Patients (13) Bone (13) Patients (13) Osteoporosis (9) Treatment (8) âge (7) densité (7) Density (7) Density (7) Age (7) Age (7) Fractures (7) gestion (6) Women (6) Management (6) Human beings (6) Fractures (6) Evaluation (6) Management (6) Women (6) Fracture (6) thérapie (5) risque (5) minéral (5) maladie (5) Values (5) Therapeutics (5) Risk (5) Population (5) Months (5)

Documents écrit par B. Aubry-Rozier (20) | parle de B. Aubry-Rozier (0)

Diurnal Salivary Cortisol in Sarcopenic Postmenopausal Women: The OsteoLaus Cohort.
E. Gonzalez Rodriguez et al.
Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
B. Aubry-Rozier et al.
Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review.
C. Camponovo et al.
Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years.
B. Möller et al. (1 juil. 2020)
Osteogenesis imperfecta: towards an individualised interdisciplinary care strategy to improve physical activity and quality of life.
B. Aubry-Rozier et al. (28 juin 2020)
Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252).
E. Gonzalez-Rodriguez et al.
Impact of a fracture liaison service on patient management after an osteoporotic fracture: the CHUV FLS.
B. Aubry-Rozier et al. (2018)
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.
C. Meier et al. (5 sept. 2017)
Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives.
A. Bregou Bourgeois et al. (2016)
Risks and benefits of percutaneous vertebroplasty or kyphoplasty in the management of osteoporotic vertebral fractures.
O. Lamy et al. (2014)
Effects of anti-resorptive agents on trabecular bone score (TBS) in older women.
M.A. Krieg et al. (2013)
Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?
D. Stoll et al. (2013)
What was your fracture risk evaluated by FRAX(®) the day before your osteoporotic fracture?
B. Aubry-Rozier et al. (2013)
Changing the awareness of low vitamin D status in a rheumatology population: a pre/post-study.
D. Stoll et al. (2013)
Voriconazole-induced periostitis.
C. Rossier et al.
Ostéoporose : les fractures non traumatiques de la personne âgées
M. Sanduloviciu et al. (2012)
TBS en routine clinique: propositions d'utilisation - L'apport de la texture osseuse dans la prise en charge des ostéoporoses
C. Cormier et al. (2012)
High prevalence of hypovitaminosis D in a Swiss rheumatology outpatient population.
D. Stoll et al. (2011)
A single high dose of oral vitamin D3 is insufficient to correct a deficiency in a rheumatologic population
D. Stoll et al. (2011)
IVA in addition to BMD can change the osteoporosis management in 25% of clinical routine patients
B. Aubry-Rozier et al. (2011)